Vitamin a shown to protect tiny Preemies' lungs

NCT ID NCT07577180

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether giving very low birth weight preterm infants (born at or before 32 weeks, weighing under 1250 grams) a weekly high-dose oral vitamin A supplement could reduce their risk of developing bronchopulmonary dysplasia (BPD), a chronic lung disease. The trial randomly assigned 209 babies to receive either the vitamin or standard care. The goal was to see if this simple, low-cost approach could lower the number of infants needing oxygen at 36 weeks and improve overall outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRONCHOPULMONARY DYSPLASIA (BPD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kocaeli City Hospital

    Köseköy, Kocaeli, 41060, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.